Stock A119610 INTEROJO INC.
Add to a list
To use this feature you must be a member
Log inSign up

Ratings Interojo Inc.

Equities

A119610

KR7119610004

End-of-day quote Korea S.E.
Other stock markets
 06:00:00 2024-04-04 pm EDT 		5-day change 1st Jan Change
24,900 KRW -15.74% Intraday chart for Interojo Inc. -.--% -21.20%
May. 16 Interojo Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Apr. 15 Interojo Inc.(KOSDAQ:A119610) dropped from S&P Global BMI Index CI

Summary

  • The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.

Strengths

  • According to sales estimates from analysts polled by Standard & Poor's, the company is among the best with regard to growth.
  • The company's profit outlook over the next few years is a strong asset.
  • Before interest, taxes, depreciation and amortization, the company's margins are particularly high.
  • The company returns high margins, thereby supporting business profitability.
  • Thanks to a sound financial situation, the firm has significant leeway for investment.
  • The equity is one of the most attractive in the market with regard to earnings multiple-based valuation.
  • The company has a low valuation given the cash flows generated by its activity.
  • Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
  • The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
  • The opinion of analysts covering the stock has improved over the past four months.
  • The divergence of price targets given by the various analysts who make up the consensus is relatively low, suggesting a consensus method of evaluating the company and its prospects.

Weaknesses

  • For the last twelve months, sales expectations have been significantly downgraded, which means that less important sales volumes are expected for the current fiscal year over the previous period.
  • The sales outlook for the group was lowered in the last twelve months. This change in forecast points out a decline in activity as well as pessimistic analyses of the company.
  • The group usually releases earnings worse than estimated.

Ratings chart - Surperformance

Sector: Medical Equipment, Supplies & Distribution

1st Jan change Capi. Investor Rating ESG Refinitiv
INTEROJO INC. Stock Interojo Inc.
-21.20% 226M -
ESSILORLUXOTTICA Stock EssilorLuxottica
+14.98% 103B
B
THE COOPER COMPANIES, INC. Stock The Cooper Companies, Inc.
-0.24% 18.79B
B-
AUTEK CHINA INC. Stock Autek China Inc.
-22.28% 2.17B
D+
WARBY PARKER INC. Stock Warby Parker Inc.
+17.94% 1.98B
C+
PEGAVISION CORPORATION Stock Pegavision Corporation
+20.05% 1.14B -
MINGYUE OPTICAL LENS CO.,LTD. Stock Mingyue Optical Lens Co.,Ltd.
-41.45% 679M -
UNIVERSAL VISION BIOTECHNOLOGY CO., LTD. Stock Universal Vision Biotechnology Co., Ltd.
-7.76% 667M -
MENICON CO., LTD. Stock Menicon Co., Ltd.
-45.13% 628M
B-
SHANGHAI CONANT OPTICAL CO., LTD. Stock Shanghai Conant Optical Co., Ltd.
+56.94% 605M - -
Investor Rating
Trading Rating
ESG Refinitiv
-

Financials

Sales growth
Earnings Growth
EBITDA / Sales
Profitability
Finances

Valuation

P/E ratio
EV / Sales
Price to Book
Price to Free Cash Flow
Yield

Momentum

1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision

Consensus

Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
12m Revision of opinion

Business Predictability

Analyst Coverage
Divergence of Estimates
-
Divergence of analysts' opinions
Divergence of Target Price
Earnings quality
  1. Stock Market
  2. Equities
  3. A119610 Stock
  4. Ratings Interojo Inc.